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ABSTRACT

This thesis utilizes the example of Gardasil to better understand the dynamics of
power at play in discourses of health in the United States, and to identify the neoliberal
tenors of some contemporary public health strategies. A neoliberal turn in public health,
while not all encompassing, has resulted in distorted and limited conceptions of health
that rely on consumerism and notions of personal responsibility. With the example of
Gardasil, Merck has deployed age-old tropes that pre-date, and are strengthened by, this
neoliberal turn. These tropes–of women and girls as simultaneously at-risk and risky
subjects, of young women‘s bodies in need of state protection, and of immigrants as
sources of contagion–strategically displace the focus from the actual risk factors and
causes of HPV-related deaths in the U.S. and contribute to an understanding of health as
a private issue, privileging consumerism over prevention, and profit over public health.
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Introduction
In June 2006, Gardasil, a vaccine produced by Merck & Company, Inc. (Merck)
to prevent human papillomavirus (HPV) infection, was approved for use by the Food and
Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)
and introduced to the American market. Various constituencies were soon bombarded
with information about the vaccine, via routes strategically charted by Merck–consumer
oriented advertising, legislative health policy debates, and medical recommendations, as
well as through discourses well out of the pharmaceutical company‘s purview, including
those of women‘s health and immigrants‘ rights advocates, members of the anti-vaccine
movement, abstinence proponents and reproductive justice activists. The vaccine targeted
a sexually transmitted infection linked to cervical cancer and genital warts in girls and
women ages nine to twenty-six and was simultaneously hailed as a crucial, pro-woman,
public health strategy and as an example of the use and abuse of public health policy
influenced by state and pharmaceutical interests.1
This thesis utilizes the example of Gardasil to better understand the dynamics of
power at play in discourses of health in the United States, and to identify the neoliberal
tenors of some contemporary public health strategies. A neoliberal turn in public health,
while not all encompassing, has resulted in distorted and limited conceptions of health
that rely on consumerism and notions of personal responsibility. With the example of
Gardasil, Merck has deployed age-old tropes that pre-date, and are strengthened by, this
1

Gardasil has since been approved for use by boys and men ages nine to twenty-six (in October,
2009). ACIP endorsed the vaccine for boys and men ages eleven to twenty-one in October 2011. For more
see: U.S. Food and Drug Administration. ‖FDA Approves New Indication for Gardasil to Prevent Genital
Warts in Men and Boys,‖ Food and Drug Administration, http://www.fda.gov/NewsEvents/Newsroom/
PressAnnouncements/ucm187003.htm (accessed October 29, 2011); Gardiner Harris, ―Panel Endorses
HPV Vaccine for Boys of 11,‖ The New York Times, October 26, 2011.
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neoliberal turn. These tropes–of women and girls as simultaneously at-risk and risky
subjects, of young women‘s bodies in need of state protection, and of immigrants as
sources of contagion–strategically displace the focus from the actual risk factors and
causes of HPV-related deaths in the U.S. and contribute to an understanding of health as
a private issue, privileging consumerism over prevention, and profit over public health.
Neoliberalism as an ideology assumes that a free market guarantees individual
freedoms, which in turn maximizes social good. It brings notions of individual rights,
responsibility and consumerism to the fore.2 Merck‘s promotion of Gardasil illustrates a
simultaneous utilization of 1) neoliberal discourse focused on market solutions,
individual autonomy, consumer choice and risk management; and 2) contamination
discourse that constructs immigrant and female bodies as risky and at risk. The stratified
marketing of Gardasil reflects the ways in which the industry utilizes these discursive
strategies to ensure a broad market for their products and contributes to the struggles over
definitions of public health.
This thesis focuses on Merck‘s own advertising campaigns placed in
contradistinction to an early HPV vaccination mandate for immigrant women in the
United States and legislative efforts to mandate HPV vaccination for sixth grade girls in
New Mexico. Through a mixed methods approach, I place Merck‘s multipronged
marketing strategies in conversation with focus groups conducted with vaccine-eligible,
adolescent girls and caregivers in three communities in New Mexico.3 After a brief
2

David Harvey, A Brief History of Neoliberalism (New York: Oxford University Press, 2005).
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While working on my master‘s in American Studies at the University of New Mexico, I was
fortunate to work as a research assistant with a team working out of the Department of Family and
Community Medicine on a project entitled ―Participatory Research to Understand the Translation of the
HPV Vaccine‖ led by Andrew Sussman, PhD, MCRP (Principal Investigator) and Deborah Helitzer, ScD
(co-investigator). The project, entitled ―Participatory Research to Understand the Translation of the HPV
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explanation of human papillomavirus and the HPV vaccine Gardasil, I outline the
context which produced the HPV vaccine. Through examinations of federal and state
HPV vaccination mandates and Gardasil advertisements targeting mothers and
adolescent girls, I explore the ways in which the pharmaceutical industry utilizes
neoliberal and contamination discourse to shape public health policy and practice.

Background
HPV Transmission
In order to understand the debates around HPV vaccination it is important to
know a few things about HPV and the vaccine itself. Human papillomavirus is
transmitted through anal, oral, and vaginal sex and genital-to-genital contact. Infection is
positively associated with the number of sex partners an individual has: the more
partners, the higher the likelihood of HPV infection. No symptoms are necessary for
transmission. While condoms, dental dams and other forms of barrier protection can help
lower the risk of HPV transmission during certain sex acts, they do not provide full
protection since HPV can infect areas left exposed. The only way to completely prevent
the possibility of HPV infection is to avoid all intimate contact.4 Realistic discussions
about HPV prevention must acknowledge that the infection is transmitted through sexual

Vaccine,‖ combined quantitative survey methods with qualitative participatory research to better
understand the development and implementation of HPV vaccine dissemination policy in New Mexico.
The research we conducted around the state serves as the basis for much of my work here. In the focus
groups referred to herein, facilitators reviewed basic information about HPV and Gardasil before launching
into larger discussions. We also provided print copies of the two magazine advertisements included here in
the appendix as an elicitation technique for discussion.
4

Centers for Disease Control and Prevention. "Sexually Transmitted Diseases (STDs): Genital
HPV Infection-Fact Sheet," Centers for Disease Control and Prevention, http://www.cdc.gov/std/hpv/
stdfact-hpv.htm (accessed April 24, 2011).

3

contact. Unfortunately, adolescent sexuality is rarely explicitly acknowledged in the
consumer marketing and legislative efforts promoting vaccination as a preventive
measure.

HPV Infection
HPV is one of the most common sexually transmitted infections in the world. In
the United States, at least fifty percent of all sexually active adults will get HPV at some
point in their lives. Some estimates place this number as high as eighty percent.
Approximately twenty million Americans are currently infected with HPV, and six
million new infections develop annually.5 While HPV can lead to cancers across
gendered categories, most scientific and public attention has focused primarily on its
relationship to cervical cancer in women.6 This link is of particular concern because
thirteen of the more than forty types of genital HPV are known to be necessary precursors
of the two most common forms of cervical cancer: squamous cell carcinoma which

5

Ibid.

6

While important, focusing primarily on cervical cancer, and not on anal, penile, oral, or other
HPV related cancers displaces the focus from prevention of all HPV transmission and related cancers to
those which are assumedly heterosexual and female. For more on this see Steven Epstein, "The Great
Undiscussable: Anal Cancer, HPV, and Gay Men's Health," in Three Shots at Prevention: The HPV
Vaccine and the Politics of Medicine's Simple Solutions, edited by Keith Wailoo, Julie Livingston, Steven
Epstein and Robert Aronowitz (Baltimore: The Johns Hopkins University Press, 2010). With Gardasil’s
approval for boys and men ages nine to twenty-six, vaccine marketing and scientific research has expanded
some to acknowledge ―male‖ cancers but mainstream rationale for male vaccination is generally limited to
the prevention of genital warts and HPV transmission to assumedly female partners. This points to the ways
that heteronormativity frames the pharmaceutical industry‘s investments, and shapes gendered
understandings of subjects at risk.

4

makes up over seventy percent of cervical cancer diagnoses, and adenocarcinoma which
accounts for close to twenty percent.7
Given such high rates of infection in the United States, it seems clear that HPV
would be understood as a public health problem. There are two important things to
consider, however. First, ninety percent of all HPV infections go away on their own
within two years. Second, the United States has an incredibly effective screening and
treatment infrastructure in place which enables early detection and treatment for high-risk
strains of HPV.8 HPV related mortality rates in the U.S., while serious, are low compared
to the rest of the world. Nationally, close to ten percent of women with high-risk strains
of HPV will develop persistent infections that place them at risk for genital warts and
cancer. Very few people who have HPV in the U.S. will actually get HPV related cancers
and even fewer will die from them. For example, cervical cancer is diagnosed in 12,000
women annually, with an estimated 3,670 deaths per year.9 Those whose cases do result
in death are important to acknowledge, but they may attest more to the failings of the
health care system in this country than to the urgent need for widespread HPV

7

Jill Barnholtz-Sloan, Nitin Patel, Dana Rollison, Karl Kortepeter, Jill MacKinnon, and Anna
Giuliano. "Incidence trends of invasive cervical cancer in the United States by combined race and
ethnicity," Cancer Causes Control (2009); Elizabeth Garner. "Cervical Cancer: Disparities in Screening,
Treatment, and Survival," Cancer Epidemiology, Biomarkers & Prevention (2003).
8

Barnholtz-Sloan et al., 2009; Centers for Disease Control, 2009; Garner, 2003. Serious strains of
HPV can cause genital warts, recurrent respiratory papillomatosis (warts inside the throat), cervical cancer,
and cancers of the vulva, vagina, penis, anus, head and neck (including cancers of the tongue, tonsils and
throat).
9

CDC, 2009. Other HPV related cancers include: 3,700 cases of vulvar cancer; 1,000 cases of
vaginal cancer; 1,000 cases of penile cancer; 2,700 cases of anal cancer in women; 1,700 cases of anal
cancer in men; 2,300 cases of head and neck cancers in women; and 9,000 cases of head and neck cancers
in men (many of these head and neck cancers are related to smoking and drinking rather than HPV) per
year.
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vaccination. With more accessible screening, most serious cases of HPV can be identified
and treated before they turn into cancer.10

Cervical Cancer Screening
Papanicolaou (Pap) smear screening was introduced in the United States in the
1940s and significantly reduced the incidence of invasive cervical cancer in the following
decades. Most cervical cancers take years to develop, so Pap smear screening can
generally identify precancerous changes in order to treat abnormalities before they
develop into cancer.11 Paps, and the early treatment that they enable, are largely
responsible for the relatively low rates of cervical cancer incidence and prevalence in the
United States as compared to many other countries with lower screening rates.12
Despite that progress, significant economic, racial, and ethnic disparities exist in
the rates of screening and in the incidence of cervical cancer in different populations.
Poor women are generally diagnosed later and are more likely to die from cervical cancer
than middle class women.13 Hispanic, African American and Vietnamese women in the
United States exhibit higher rates of cervical cancer incidence and death from cervical

10

Sujana Movva, Anna-Michelle Noone, Mousumi Banerjee, Divya A. Patel, Kendra Schwartz,
Cecilia L. Yee and Michael S. Simon. "Racial Differences in Cervical Cancer Survival in the Detroit
Metropolitan Area," Cancer (2008).
11

Barnholtz-Sloan et al., 2009; Garner, 2003; Ravie Kem and Kenneth C Chu. "Cambodian Cancer
Incidence Rates in California and Washington, 1998-2002," Cancer (2007). In the United States, when a
Pap smear shows abnormal cervical cells, colposcopy is used to examine the cervix under magnification
which allows for the identification of abnormal or precancerous cells and potentially for cervical biopsies.
Biopsies that show low-grade abnormalities are monitored while high-grade lesions or cancers are treated.
12

Barnholtz-Sloan et al., 2009; Kem and Chu, 2007. Invasive cervical cancer is the second most
frequently diagnosed cancer in women globally, with close to 500,000 women diagnosed and 274,000
deaths annually.
13

Garner, 2003.
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cancer than non-Hispanic white women.14 Watson et al. note that in 2003 for every
100,000 women in the United States, fourteen Hispanic women, thirteen African
American women, eight Asian/Pacific Islander women and eight non-Hispanic white
women were diagnosed with cervical cancer.15 This is not to say that being poor or of
color is a causal factor in HPV infection or cervical cancer incidence. Rather, these
statistics demonstrate the barriers to access to adequate, affordable and appropriate health
care that exist for poor women and women of color in the U.S. The disparities described
here reflect structural inequities. They are deeply political and enable misinterpretations
of health data which result in pathologizing communities and perpetuating
understandings of certain populations as ―risky‖ or ―at risk.‖ These factors play a large
role in determining who receives HPV health education and whether a woman who has
HPV gets the necessary screening and monitoring, whether persistent infections are dealt
with before cancer develops, and whether treatment is available. With access to frequent
screening and treatment, cervical cancer deaths are largely preventable.16
The global demand for cervical cancer prevention, coupled with the inroads that
technoscientific enterprises have made into the study of HPV, has resulted in prevention
efforts that revolve primarily around vaccines that prevent cervical cancer (and

14

Maria E. Fernandez, Jennifer D. Allen, Ritesh Mistry, and Jessica A. Kahn. "Integrating Clinical,
Community, and Policy Perspectives on Human Papillomavirus Vaccination," Annual Review of Public
Health 31 (2010).
15

Meg Watson, Mona Saraiya, Vicki Benard, Steven S. Coughlin, Lisa Flowers, Vilma
Cokkinides, Molly Schwenn, Youjie Huang and Anna Giuliano. "Burden of cervical cancer in the United
States, 1998-2003," Cancer 113 (November 2008).
16

While the language of health ―disparities‖ works to identify structural inequity that results in
disparate health outcomes, it has also been criticized for depoliticizing health inequities, and for enabling
misinterpretation of health data resulting in perpetuating understandings of certain populations as ―risky‖ or
―at risk‖. The indicators noted here illustrate and simultaneously hide failings of the health system.

7

secondarily, genital warts).17 There are very real reasons to focus on developing an HPV
vaccine for use in countries where Pap smears are not standard practice. In the U.S.,
where significant screening infrastructure exists, however, resources spent promoting
legislative policy mandating HPV vaccination may be better utilized in efforts to improve
health care access and cervical cancer screening.

Gardasil
Gardasil, a quadrivalent vaccine produced by pharmaceutical giant Merck &
Company, Inc. and introduced to the U.S. market in June of 2006, prevents infection by
the two types of HPV (sixteen and eighteen) that are responsible for over seventy percent
of cervical cancers and the two types (six and eleven) that cause over ninety percent of
anogenital warts. Since the vaccine is most effective if given prior to sexual activity,
(ensuring that patients have not yet been exposed to HPV), the CDC and Advisory
Committee on Immunization Practices (ACIP) of the Department of Health and Human
Services (DHHS), recommend HPV vaccination for girls ages eleven and twelve with
catch-up vaccination approved for thirteen to twenty-six year-old girls and women in the
United States. In 2011, ACIP extended their recommendation to include boys and men
ages eleven to twenty-one. The vaccine is expensive, costing approximately $130 per
shot with three required doses for a total expense of $390 for completion of vaccination
(not including the cost of a clinical visit and other related expenses).18

17

Steven Epstein points to the ways in which anal cancer, though widespread in the United States
with current diagnoses of 3,050 women and 2,020 men each year, is left out of public discourse of HPV
and HPV vaccination because of its association with nonnormative, specifically gay, male sex. See Epstein,
―The Great Undiscussable,‖ 61-90.
18

Fernandez et al., ―Integrating Clinical, Community‖ 2010; Harris, 2011.

8

Clinical trials of Gardasil, which included over 21,000 women, show ninety to
one hundred percent efficacy in preventing HPV types sixteen and eighteen in
participants who were not infected with those types before vaccination and if they
received all three shots required in the vaccine series in the recommended time period. In
addition, the vaccine was nearly one hundred percent effective in preventing
precancerous vaginal and vulvar lesions. Though the study period was not long enough
for cancer to develop, the vaccines‘ capacity to prevent cervical cancer was extrapolated
from the successful prevention of cervical precancerous lesions. Two additional studies
were used to support the claim that women and girls ages nine to fifteen would have
similar immune responses to the vaccine as the sixteen to twenty-six year-olds included
in the trials.19
The FDA approved Gardasil on a special fast track review process approved for
pharmaceuticals with the potential to ―significantly benefit health.‖ The review process
itself was completed in only six months.20 Clinical trials, in conjunction with active
vaccination of the American public over the past five years, attest to the relative safety of
the vaccine. The trials did not reveal any serious, short term, adverse events.21 Since the
vaccine is so new, however, there is no proof of its efficacy, or safety, past five years.22

19

Fernandez et al., ―Integrating Clinical, Community,‖ 2010; Elizabeth R. Sheyn, "An Accidental
Violation: How Required Gardasil Vaccinations For Female Immigrants To The United States Contravene
International Law," Nebraska Law Review 88 (2010).
20

Sheyn, 2010.

21

Sylvia Law, "Human Papillomavirus Vaccination, Private Choice, and Public Health." UC Davis
Law Review 41 (June 2008).
22

Centers for Disease Control and Prevention, "Vaccine Safety: Reports of Health Concerns
Following HPV Vaccination," Centers for Disease Control and Prevention, http://www.cdc.gov/
vaccinesafety/vaccines/hpv/gardasil.html (accessed April 24, 2011). Since 1989, the National Childhood
Vaccine Injury Act‘s Vaccine Adverse Event Reporting System (VAERS) requires physicians to report any

9

The public response to the HPV vaccine has been a mix of celebration,
acceptance, skepticism and fear. Some criticism is based on the relatively short period of
time that the vaccine was tested before being released to the public, and the relatively
small trial size.23 Trials did not evaluate the impacts of receiving only one or two shots in
the three shot series. This is important because many women and girls begin the series
but do not complete it–for a number of reasons, including cost.24 Since trials did not test
what happened when the vaccination series was incomplete, it is difficult to evaluate the
risks and benefits of encouraging vaccination of such an expensive vaccine with low
completion rates. As a medical technology addressing issues of sexual health, Gardasil
provides a timely opportunity to understand the ways in which the industry of medicine
and the field of public health have grown and transformed.

Gardasil in Context
Neoliberalism and Public Health in the United States

vaccine related adverse events to the CDC and FDA. Thirty-three million doses of Gardasil had been
distributed in the United States as of February 14, 2011 and 18,354 incidents of adverse events had been
reported to VAERS. Of events reported, ninety-two percent were considered to be non-serious (fainting,
pain and swelling at site of injection, headache, nausea, and fever), and eight percent were considered
serious (requiring hospitalization, permanent disability, life-threatening illness, congenital anomaly or
death). Serious reported events include Guillain-Barré syndrome; blood clots in the heart, lungs and legs;
and fifty-one reports of death (thirty-two of which have been confirmed). As with all VAERS data, there is
no clear way to determine if reported events are actually caused by the vaccine. According to the CDC, in
the case of Guillain-Barré syndrome the reports reflect the number of cases in the general population and
do not indicate increased risk due to vaccination. Women and girls who reported blood clots generally
shared risk factors unrelated to vaccination (i.e. they were smokers, took oral contraceptives etc.). A
number of the deaths indicated a cause of death unrelated to the vaccine. When a patient dies within the
reporting period, they are included in the VAERS report even if there is no obvious link.
23

Law, 2008.

24

Also, the early federal mandate - which required certain immigrant women to show proof of
vaccination - only required that those women get the first in the three-shot series.

10

In the United States the institution of public health is premised on a belief in
necessary medical paternalism at the state level which enables the protection of the
nation‘s health through social policies and preventive measures.25 Public health policies
and practices are shaped by a commitment to the health of populations rather than
individuals.26 As an institution, public health runs counter to the anti-statist ideology and
narrow framing of individual rights that typify neoliberal policy. John Stuart Mill‘s harm
principle–that the only justifiable instance when the state can exercise power over an
individual member of society against their will is when it protects others from harm–was
used as the basis for public health interventions throughout the twentieth century. Legal
and human rights frameworks rely on this notion and allow for government intervention
into private lives to protect the larger population.27 Such intervention is justified by a
social contract of sorts, contingent upon the implicit consent of those populations being
25

Robert Bayer and Amy L Fairchild. "The Genesis of Public Health Ethics." Bioethics 18 (2004):
473-492. In their work to define an ethics of public health, Bayer and Fairchild note that ―those involved in
the practice of public health embrace a set of values that are often, if not always, in conflict with the
autonomy-centred values of those who take an individualistic and anti-paternalistic stance‖ (Bayer and
Fairchild, 488).
26

James Colgrove, Gerald Markowitz, and David Rosner, "Introduction: The Contested
Boundaries of Public and Population Health." In The Contested Boundaries of American Public Health,
edited by James Colgrove, Gerald Markowitz and David Rosner, (New Brunswick: Rutgers University
Press, 2008).The majority of public health activities in the nineteenth and early twentieth centuries focused
on limiting the spread of epidemic diseases in populations (cholera, smallpox, typhoid) through sanitation
projects, quarantine, surveillance, and vaccination campaigns. In the early 1900s, public health authorities,
as empowered by the activist state, employed their police powers to implement programs of risk
management and surveillance. While the population level priorities of public health always differed from
the individual priorities of clinical medicine, the two fields formally split in the 1920s. Colgrove et al. note
that ―[t]he medical profession claimed authority over the domain of most individual patients, while public
health retained narrow responsibility for a few perennially unpopular categories of care that the medical
profession didn‘t want to provide: services for the indigent, treatment of sexually transmitted diseases, and
control of once-epidemic but increasingly vestigial contagions such as tuberculosis and smallpox‖
(Colgrove, Markowitz and Rosner, 5).
27

Bayer and Fairchild, 2004; John Stuart Mill, On Liberty. (New York: Longman's, Green and
Company, 1913).
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protected and the assumed benevolence of the state. While geared towards protecting
populations, this ―contract‖ relies on an abstract, liberal notion of equality that does not
reflect the true dynamics of power and privilege in the U.S. The danger here is that the
needs of individuals and populations who are excluded from full national participation
are neglected.
Public health is largely managed at the state and local level where legislators,
health advocates and other policy shapers effectively set the parameters for certain health
practices and decisions for the ―public.‖ General police powers enable states to enact
legislation intended to protect the public‘s health. While U.S. constitutional and common
law clearly establish that individual adults have the right to make their own medical
decisions and that parents can make such decisions for their young children, the tenets of
public health validate policies that privilege population health over individual choice.28
While it is important to understand the ways in which public health policies
generally work for health equity, it is also necessary to interrogate the motivations behind
such policies in order to ensure that they are indeed working towards benevolent ends. In
addition to the important successes of the U.S. public health system, discourses and
practices of public health have also been used to construct notions of good and bad
citizens and to rationalize inequality, marginalization, and the exclusion of certain
populations from full national participation.29

28

Law, 1751.

29

See Emily K. Abel, "From Exclusion to Expulsion: Mexicans and Tuberculosis Control in Los
Angeles, 1914-1940." Bulletin of the History of Medicine 77 (2003): 823-849; Natalia Molina, "Borders,
Laborers, and Racialized Medicalization: Mexican Immigration and US Public Health Practices in the 20th
Century." American Journal of Public Health (April 2011): e2-e9; Natalia Molina, Fit to Be Citizens?
Public Health and Race in Los Angeles, 1879-1939. (Berkeley: University of California Press, 2006);

12

Social movements committed to civil rights and equality in the 1960s, feminism
and women‘s health in the 1970s and a focus on the rights of the consumer in the 1980s
all altered the way medicine and public health were understood and practiced in the U.S.
Some of these movements focused specifically on preventing medical exploitation and
neglect and on expanding access to medical care for underserved communities. Others
focused on strengthening the individual rights of health consumers. The resulting notions
of informed consent and patients‘ rights which shifted the dynamics of power in medical
practice and public health, were utilized both by those activists working for health equity
and justice and those pushing a neoliberal agenda where autonomy and individual
responsibility took precedent.30
As neoliberalism permeated U.S. politics in the late twentieth century, longpresent notions of individual rights, personal responsibility and consumerism shaped the
discourses through which people came to understand health and disease.31 Marxist
Nayan Shah. Contagious Divides: Epidemics and Race in San Francisco's Chinatown. (Berkeley:
University of California Press, 2001).
30

Bayer and Fairchild, 2004; Susan E. Bell and Anne E Figert, "Gender and the Medicalization of
Healthcare." In The Palgrave Handbook of Gender and Healthcare, edited by Ellen Kuhlman and Ellen
Annandale (Palgrave Macmillan, 2010) 107-122; Angela Coulter, "Paternalism or partnership? Patients
have grown up - and there's no going back." British Medical Journal 319 (September 1999): 719-720.
31

Dorthy Porter, Health, Civilization, and the State: A History of Public Health from Ancient to
Modern Times. (Routledge, 1999). The application of neoliberal values to health has both deepened and
challenged paternalistic medicine in the United States. Early public health reforms in the United States
were rooted in Puritan morality (invested in social cleanliness and its relationship to godliness) rather than
a centralized state power (as in Great Britain). Such practices were associated with paternalistic charity –
wealthy members of society providing for the needy through sanitation reforms to protect the health of the
masses. In early nineteenth century America, as the rural population became more urban, ―[p]overty was no
longer seen as a charitable estate by the wealthy, who increasingly blamed the poor for their condition. .
.Paternalism gave way to a rising tide of rugged individualism in which community responsibility was
dismissed in favor of the importance of individual self-sufficiency‖ (Porter, 1999, 148). As notions of
individualism deepened, and as industry expanded, self-sufficiency won out over community-oriented
policies. The practice of blaming individuals for their predicaments, including ill-health, has receded and
reemerged ever since.
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geographer David Harvey defines neoliberalism as ―a theory of political economic
practices that proposes that human well-being can best be advanced by liberating
individual entrepreneurial freedoms and skills within an institutional framework
characterized by strong private property rights, free markets, and free trade.‖32 While the
state provides the institutional framework, neoliberal values require the withdrawal of
state support, limited state intervention, deregulation and privatization.33
Arguments that personal habits and lifestyle choices were the actual cause of an
unhealthy country circulated in academic and policy circles in the 1970s, strengthening
conservative efforts that challenged the utility of government intervention, through public
health initiatives, for ―personal‖ issues like drug abuse and sexually transmitted diseases.
Neoliberal ideologues underlined the point that the responsibility for health problems lay
with individuals rather than with structural inequities, argued that health solutions were
the responsibility of the individual rather than the government, and looked to the market
for their consumerist fix.
The ascendance of neoliberalism in national politics in the United States in the
late twentieth century coincided with the rise of medicalization in everyday life. Medical
sociologist Irving Zola first articulated the concept of medicalization, in the 1970s, in
order to capture the ways in which people‘s lives were increasingly brought under
medical jurisdiction in the twentieth century.34 Conrad and Schneider refer to this shift as
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the move from ―badness to sickness‖.35 Zola understood this process as a reflection of the
societal desire for technical solutions to social problems. Once an issue becomes
medicalized at the individual level the medical route provides the only rational solution,
effectively disallowing for any other types of intervention or response.36 Building on
legacies of medical paternalism, medicalization explicitly reaffirmed the importance of
medicine in people‘s lives, normalized the medical diagnosis of previously non-medical
issues and their concomitant medical solutions, and brought additional conditions under
the capitalist project of medicine. Medicalization worked to obscure larger structural
causes of health inequities and focused on individual ―health,‖ with an emphasis on
treatment rather than prevention.37 This focus on individual responsibility and market

medicalization which redefined the way health was understood. ―Conditions‖ that were previously
recognized as social or legal became medicalized (alcoholism, sexuality). The results were complicated.
Understanding certain issues in medical terms often removed individual blame or shame and enabled
access to care and treatments. In other cases, such medical labeling resulted in stigmatization and the
perpetuation of stereotypes and blame.
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solutions both embraced and was embraced by neoliberal ideology and was used to
justify the withdrawal of the state in matters of population, or public, health.
The attack on ―big-government‖ ushered in by Ronald Reagan in the 1980s
contributed to a national ethos that made it difficult to advocate for public health efforts
that focused on the prevention of conditions that were increasingly being framed as the
result of individual choice and lifestyle.38 This mentality went hand in hand with
deregulation of industry and the defunding of federal social programs which also had
severe implications for health. In a drastic shift from addressing health at the population
level through political efforts, preventive medicine became more focused on individual
lifestyles.39 Public health became much less public. The promise of consumer citizenship
implied in neoliberal discourse forwarded pharmaceutical consumption as a means to
take responsibility for one‘s own health. Nancy Tomes notes that ―[r]ather than acting
collectively in political or policy domains, enlightened consumers were to make their
wishes known by the exercise of individual choice: to discipline the marketplace by
choosing to enroll in an HMO . . . to abstain from risky behaviors such as smoking or
unprotected sex,‖40 or to pop the right pill for what ailed them. Public policy, and public
health efforts, continue to bear the mark of this neoliberal turn. The capitalist
undercurrents of medicalization–the sense that for every problem there is a medical
solution that can be bought–work in tandem with the increasing emphasis on individual
38
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health promoted in neoliberal discourse as individual rights, autonomy, and choice. The
result has been a privatization of health and health care, and the increased understanding
of health as a consumer issue.

Risky Subjects / Subjects at Risk
Medicalization works to frame all people as potential patients, and all patients as
in need of medical expertise and guidance. Certain bodies, however, are constructed as
especially in need of this direction. Women, communities of color and immigrants have
too often and unjustly been identified, through medical and public health practice, as
vectors of disease emergence and as in need of medical intervention. This has effectively
limited these groups from participating fully in their own health decision-making and in
U.S. society. Placing Gardasil in this context helps to understand the passionate response
to proposed mandates for HPV vaccination.
Mandates around issues of sexual health invoke a long history of the ways in
which certain populations have been labeled as ―risky,‖ posing a threat to the health of
the nation and in need of state intervention, or as ―at risk‖ and in need of state protection.
This dynamic is similarly expressed in characterizations of certain people who get sick as
innocent victims, and others as deserving of their illness–especially when it comes to
issues of sexual health. Gardasil advertising frames vaccination as an empowering act for
mothers and girls choosing to manage their own health risks, while state mandates were
justified as a response to a pressing need to protect young girls at risk of getting cervical
cancer, and the federal mandate reflected assumptions about the riskiness of immigrant
women as potential sources of contagion.
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Medical sociologist Adele Clarke and her colleagues offer the concept of
biomedicalization in an attempt to name the ways in which neoliberal discourse and
values have become normalized in the health arena since the mid-1980s.
Biomedicalization captures the ways in which the process of medicalization has changed
and expanded with the growing reliance on technoscience in biomedicine through five
basic processes: ―(1) privatization and commodification, (2) risk and surveillance, (3)
expanding technoscientific practices, (4) the production and distribution of knowledges,
and (5) transformations of bodies and subjectivities.‖41
A core component of the process of biomedicalization is the use of the concept of
―risk‖ to construct all bodies as always potentially ill or in the process of becoming ill.
Risk factors, then, help to identify the signs of this potentiality in individuals and
populations. Symptoms are not necessary. Foskett asserts that in the biomedicalization
era, ―at all times, everyone is potentially not normal, inhabiting tenuous spaces between
illness and health.‖42 Risk is understood as a health problem in itself, with treatments and
biomedical solutions. She notes that ―[w]ith the expansion of technoscientific tools of
biomedical surveillance into ever greater areas of people‘s bodies and lives, being ‗at
risk‘ becomes an increasingly common diagnosis, with its own set of proscriptions,
prescriptions and treatments.‖43 Clarke, Shim et al. understand this shift in Foucauldian
terms wherein the bodily discipline that results from the medical gaze extends beyond
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traditional sites of medicine to ―implicate each of us and whole populations through
constructions of risk factors, [and] elaborated daily life techniques of self-surveillance.‖44
Clarke et al. describe the stratification of biomedicalization, evident in the
different ways in which communities and identities are targeted with the example of
Gardasil. Wealthy individuals learn about ―designer‖ or ―boutique‖ biomedical services
offering the opportunity to transform, or re-make, their bodies and improve their health in
whatever ways they desire. Advertising the expensive HPV vaccine to mothers (assumed
to be citizens, with health insurance and access to health care) and tapping into their
desire to protect vulnerable daughters exemplifies this. These are innocent subjects, at
risk, and in need of protection via the choice to vaccinate. Other bodies face increasing
barriers in their attempts to access medical care and have less autonomy in their own
health decision-making. These are those risky subjects posing a threat to the health of the
nation, whose regulation is justified. Mandating vaccination, while potentially enabling
access to those considered to be the most vulnerable and in need, still results in
pathologizing particular communities. This process cannot be separated from broader
projects of racialization and differentiation of groups within the broader U.S. population.
It reflects the neoliberal discourses of health that have contributed to the process of
biomedicalization: individuals are responsible for their own health and ill-health is a
reflection of individual deficiencies. And yet, through epidemiology and public health
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interventions, the state determines which populations are at risk and which are risky (to
others). This justifies biomedical interventions, like vaccination mandates, and
pathologizes racialized and sexualized communities.45
In her ethnographic work in favelas in northeastern Brazil, Jessica L. Gregg
argues that assumptions about women‘s sexuality serve to silence women and those
silences manifest in illness–due to a lack of preventive care, dismissal of symptoms and a
tendency to blame women for their own illness. Greggs argues that ―[b]lame for the
spread of disease, particularly diseases associated with sexuality, has often illuminated
the culturally marginalized status of different groups at different times.‖46 An alternate
way of understanding this blame is as risk that carries moral implications. Maren
Klawiter‘s notion of woman as ―the risky subject‖ is also useful here in understanding
how, as with her example of breast cancer, women are encouraged to think of their heath
in terms of future risk and individual responsibility. Reflecting neoliberal narratives of
health, women‘s bodies are thus perpetually at risk and women are implicitly blamed for
not being ever vigilant.47 Much of this argument can be applied to the discourses
surrounding HPV vaccination, in which adolescent girls‘ and immigrant women‘s bodies
are framed by state and federal government as always in need of disciplining. Following
this logic, theirs are bodies that can and should be controlled, whether by parents or by
the state. Vaccination thus serves as a means to protect the nation at large from the
45
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assumed threat of racialized and sexualized adolescent and immigrant women and to
protect those young girls who have not yet been corrupted from the sources of contagion
that threaten their purity.

Mandating Pharmaceutical Solutions
While there have been too many instances when state powers have implemented
discriminatory and damaging policies in the name of public health, the life-saving work
of many public health measures is indisputable. Mandatory vaccinations are one such
measure, keeping rates of vaccine-preventable disease down in the U.S. since they were
first implemented in the 1850s.48 The intervention into individual lives that results from
such large-scale public health projects has faced popular resistance, however, and the
paternalistic role of state power fosters an always suspicious populace.49
The first compulsory vaccination laws in the U.S were put in place in the 1850s.
In Jacobson v. Massachusetts, in 1905, the U.S. Supreme Court ruled that the state had
the right to require vaccination during an epidemic. Importantly, the decision required
48
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that such vaccination orders must be in response to an epidemic and must not be enforced
through physical force. Exemptions from vaccination for those with health conditions that
might put them at risk were also included in the ruling. The Jacobson decision was used
to uphold the power of the state in determining what sacrifices were reasonable to expect
from citizens.50
Today, states across the country enforce vaccination requirements for newborns
and for public school entry. These requirements include clauses for parents and students
to opt out of required vaccination for health, religious and/or ethical reasons. Though
vaccines are hailed by many as crucial to public health and safety, a number of people
continue to see mandated vaccination in the same light as the plaintiffs in Jacobson did:
as government exercising too much control over private lives and individual choice.
Suspicion surrounding the safety of vaccines and the motivations of the pharmaceutical
industry compound critiques of public health mandates involving vaccination. HPV is a
unique case because its (sexual) mode of transmission distinguishes it from other diseases
that are highly communicable–like typhoid or measles. The question, then, is what are the
conditions under which it is justifiable to use state power to override personal autonomy,
if ever? Does the public health ―threat‖ posed by HPV meet these conditions? The way in
which Gardasil has been marketed, both as an individual and a public health strategy,
brings forth the tensions present when a pharmaceutical technology is packaged in public
health terms.
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Sociologist Simon J. Williams defines the process of pharmaceuticalization as
―the transformation of human conditions, capacities or capabilities into pharmaceutical
matters of treatment or enhancement.‖51 This concept captures the powerful role of the
pharmaceutical industry as it influences individuals and states in the regulation of bodies.
Neoliberal policies rely on individuals actively embracing their roles as health
consumers. Pharmaceuticalization more specifically relies on the normalization of
pharmaceutical technologies as the medical solutions that those health consumers seek.
Joao Biehl‘s notion of the pharmaceuticalization of public health articulates the
expansion of medicalization to the state level where drugs take the place of more
prevention-oriented public health strategies.52 This concept is useful in understanding the
context that produced the HPV vaccine. Rather than focusing on improving access to the
widespread and effective cervical cancer screening efforts in the United States, or on
other preventive measures that are more in line with traditional public health practices,
Merck worked to create a sense of urgency around the issue of cervical cancer and
produced a pharmaceutical solution in the form of a very expensive vaccine which was
51
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promoted in health policy circles as an important and necessary public health
intervention. HPV as public health epidemic appeared almost simultaneously alongside
its pharmaceutical fix and states were encouraged to purchase the vaccine as a way to
protect their vulnerable populations. This protection came in the form of vaccination
mandates at the federal and state level.
The following sections explore attempts to mandate HPV vaccination at the
federal level for women and girls attempting to become residents or citizens of the United
States and at the state level for girls entering the sixth grade. Proposed mandates, placed
in contradistinction to Merck‘s advertising efforts to health consumers, complicate what
public health means in the U.S. today. The simultaneous utilization of neoliberal and
contamination discourse illustrate the neoliberal turn in public health.

Gardasil on the Ground
Though mandates of HPV vaccination for school-entry largely failed across the
country, a mandate (at least temporarily) that was implemented with much less public
discussion and active resistance was the requirement that all immigrant girls and women
ages eleven to twenty-six show proof to U.S. Citizenship and Immigration Services that
they had received the first Gardasil shot–of the three shot series–in order to successfully
apply for a visa or to become a U.S. citizen. Due to the Illegal Immigration Reform and
Immigrant Responsibility Act of 1996, all immigrants attempting to make these changes
in immigration status must be in compliance with all of the Advisory Committee on
Immunization Practices‘s (ACIP) recommendations for residents of the United States.
The requirement, which quietly went into effect in July 2008 as a result of ACIP‘s
recommendation in 2006, makes what is a recommendation without the weight of law for
24

U.S. citizens, an official rule backed by the power of the law and the possibility of
permanent national exclusion for immigrant women. This is an undue burden not only
because of the hypocrisy there, and because of the costs associated with the shot, but also
because clinical evidence–in terms of risk and in terms of efficacy–does not exist for
instances when women only receive the first of the series of shots.53 Also, vaccination is
recommended for young women before they have had sex. For those women between the
ages of eleven to twenty-six who have already been sexually active and have been
exposed to the types of HPV that the vaccine protects against, the only reason for
vaccination is the fulfillment of an administrative requirement of the U.S. government.
This mandate can be understood as one policy in a long line of immigration policies that
have utilized health to paint immigrant populations as risky to the American public. This
riskiness justified a policy that allowed citizens to choose whether they wanted to receive
the HPV vaccine, while immigrant girls and women essentially had no choice.
I will now turn to primary source material from focus groups conducted with
women and adolescent girls in communities throughout New Mexico in order to provide
a sense of how the HPV vaccination mandates were perceived by people making their
own decisions about Gardasil. Focus groups were conducted as part of a larger study out
of UNM‘s Department of Family and Community Medicine which examined views about
health policy and decision-making for the HPV vaccine in New Mexico. Twelve focus
groups were held with caregivers of Hispanic, vaccine-eligible girls (ages twelve to
eighteen) and with girls themselves. The groups took place in three communities across
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the state of New Mexico including a northern rural Hispano community; a central urban
community with participants who identified as Hispana, Latina, Chicana, and Mexicana;
and a southern rural community with a large Mexican immigrant population. All focus
group transcripts have been de-identified. The names of participants, and the dates and
locations of the focus groups are withheld by mutual agreement.
When I spoke with these women and girls about the immigrant mandate it was no
longer a legal requirement. Regardless of this fact, the focus group participants were
highly critical about the idea of the mandate. They zeroed in on a number of its troubling
aspects and clearly articulated the ways in which immigrant women are constructed as
risky and at risk in discourses of health.
Many of the themes that came up in the focus groups illustrate the ways in which
past public health abuses frame how the HPV vaccine mandate for immigrant women
was understood by many of those opposed to its implementation. A number of women in
the groups talked about their suspicion of the pharmaceutical industry and of government
health programs more generally, invoking Tuskegee and other shameful moments in U.S.
history.
It‘s unethical I feel like, because they‘re being targeted, you know, and they‘re
probably starting with Mexican nationals. I bet you it wasn‘t like beautiful
Europeans, man, I bet you it‘s the Mexican nationals. You know, just like ‗let‘s
target these poor people that came here for a better life. And let‘s use them, you
know. So that‘s the clinical trial right there. These people are the clinical trial.
Just at looking at it, that‘s the fact. That‘s it right there. That‘s your trial, you
know, so in ten years, we‘re gonna know how many of them died, you know. If it
worked, if it didn‘t work, how many of them came to have babies, can they have
babies? Will they have babies? Cause they‘re not sick and they‘re just people.
That‘s way unethical. I can‘t believe . . . no, it‘s disgusting, not even unethical.
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Mothers were uncomfortable with the racialization of certain immigrant women and the
apparent determination that immigrant bodies were somehow lesser than those of
citizens.
Discourses of health as utilized in immigration legislation have historically
worked to define proper citizenship and determine national inclusion and exclusion
through the identification of risky populations and individual and community wide
―threats‖ of contagion–often located in immigrant bodies and communities of color.
Markel and Stern argue that ―[a]nti-immigrant rhetoric and policy have often been framed
by an explicitly medical language, one in which the line between perceived and actual
threat is slippery and prone to hysteria and hyperbole.‖54 Girls in the focus groups
understood the motivation behind the mandate in these terms. ―I think . . . it‘s to ensure
that–that if you do have one, an STD, and you come to the United States, that you‘re not
going to go and give it to other U.S. citizens. It‘s to protect us.‖ Thus, the mandate was
implemented in order to protect Americans from ―risky‖ immigrant women.
Other girls were concerned about protecting women who were coming to the
United States from unfair laws and exploitation.
I don‘t get what the whole immigrant thing has to do with being a US citizen.
It‘s like they‘re just trying to get money out of them.
Also, it‘s kind of like judging the person, ―Oh this person came from Canada,
they‘re gonna have like bacon disease‖
...
It all comes back to being like racist or something.
That‘s kind of true, yeah.
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They saw through the framing of the mandate as a way to protect vulnerable immigrant
populations and identified Merck‘s profit driven utilization of racist tropes.
In his social history of venereal disease, Allan Brandt traces the social
construction of sexually transmitted diseases, noting a shift from understanding venereal
disease as biological phenomenon to VD as social symbol. He asserts that venereal
disease is used as a symbol of corrupt sexuality and contamination of populations which
enables understandings of women as sources of moral and biological contagion and
shapes health policy responses. The ways that sexually transmitted diseases are framed
and addressed through health policy is indicative of the moral leanings of a society and
works to regulate bodies and legitimate neoliberal understandings of health.55 In the case
of HPV, risky immigrants threaten an innocent, at-risk and otherwise uninfected nation.
Such discourses of health have been formally employed as a means to exclude
immigrants to the United States since immigration came under the jurisdiction of the
federal government in the late nineteenth century.56 In many instances, individual bodies
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were literally excluded from entering the United States or prevented from joining the
ranks of full citizens through a utilization of health policy.57 The requirement of HPV
vaccination for some immigrant women and girls and not for American citizens is a clear
contemporary example of such exclusionary practices.
Many girls that I spoke with thought that a better legislative priority would be to
screen women for dangerous types of HPV rather than require them to get vaccinated.
The fact that HPV was not communicable in the same way as whooping cough or
measles made the mandate seem all the more unjust.
I think everybody should get tested, not just immigrants, because we can be
carrying it as well.
Yeah.
Like what if we gave it to the immigrant?
Not only were immigrant women being unfairly blamed for the spread of HPV in the
U.S., participants noted that they could actually be at risk of catching HPV from citizens
who were not required to get vaccinated.
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Alan M. Kraut analyzes the construction of the ―immigrant menace‖ as framed in
terms of the fear of germs and genes of foreign bodies.58 Priscilla Wald‘s analysis of what
she terms the ―outbreak narrative‖ in film and fiction illustrates the ways in which the
threat of infectious disease, as specifically linked to threats of other, foreign, bodies has
been naturalized in popular and scientific culture.59 Constructions of the threats emerging
from the developing world, threatening U.S. borders and bodies, secure notions of
national belonging. These narratives help shape who is seen as risky or as a threat to
public health, who is considered at risk, who is stigmatized, and what health related fears
are taken up by the U.S. public at large.
Outbreak narratives provide a rationale for xenophobia, isolation and fear. It takes
an interconnected, globalized world to make outbreak narratives resonate. Wald explains
that through this logic, ―[h]uman networks became the conduits of viral destruction.‖60
This fear is used to justify what Kraut calls medicalized nativism. He notes that ―[t]he
medicalization of preexisting nativist prejudices occurs when the justification for
excluding members of a particular group includes charges that they constitute a health
menace and may endanger their hosts . . . Thus, there is a fear of contamination from the
foreign-born.‖61 Wald points to the ways in which this stigmatization of immigrants relies
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on a false understanding of national borders as able to guard against disease.62 Girls in the
focus groups similarly articulated the ridiculousness of this notion.
It‘s not fair to separate people from the people [that just came here] you know.
We‘re all at risk here, you know, it‘s not like one person is completely, you know,
protected from that stuff.
We‘ve got the swine flu . . .
There‘s a lot of diseases that cross the border.
Cause the swine flu‘s all over. Does that mean that the cervical cancer‘s just
gonna like be in Europe just because they‘re more out with their sexuality?
Amy L. Fairchild argues that instead of focusing on those bodies who are turned
away at the border for health-related reasons, what is important about health policies like
immigrant health inspection is the way that they serve to discipline immigrant bodies.63
Where Wald illuminates the use of the outbreak narrative in legitimizing xenophobic
ideologies, Fairchild shows the ways that the U.S. Public Health Service historically
made use of the outbreak narrative and the discourse of risky subjects to different ends.
Fairchild argues that ―immigrant medical inspection represented a new technique for
discipline in the new social and economic order, signaling a transformation in the nature
of discipline and power, from corrective to preventive, from violent to normative. . .The
aim of discipline in the industrial era. . .was a normative expression of power intended
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not simply to prevent deviant behavior but to promote adoption of core industrial values,
to create a cadre of good industrial citizens.‖64
Both Wald and Fairchild draw on different but connected strands of Foucault‘s
theory. Wald employs Foucault‘s theory of biopolitics and argues that ―the concept of
public health was formative for modern society, and epidemics were important because
they manifested the need for protection in the form of regimented social behavior.‖65 If
people followed bourgeois norms, they would be protected from disease. Fairchild uses
Foucault‘s understanding of modernity as a moment where norms are more effective
disciplinary tools than punishment. She illustrates the ways in which normative
expressions of power at work are more effective than restrictive immigration policies.
Fairchild asserts that the pressures enacted on laborers to prove their fitness for
citizenship performed the disciplinary work of the state without burdening prisons and
other overt methods of state control. In both cases, epidemic scares and the promotion of
normative behavior work together as means of social control by the state. The HPV
vaccine fits squarely into this dynamic wherein immigrant women must utilize
pharmaceutical technologies to lessen their riskiness and prove their fitness for
citizenship.
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At times public health discourses have worked to maintain cultural and political
hegemony through utilization of the framing of immigrants as risky subjects. With the
HPV vaccine mandate, immigrant women are associated with a sexually transmitted
infection. A common theme in focus groups included a discomfort with the presumed
hyper-sexuality of immigrant women that was implicit in the vaccination requirement.
One girl noted:
What are they saying when they‘re telling these people that they have to get this
vaccine? I mean, is it their way of implying that these people have a lot of sex and
are gonna not be protected? I don‘t understand why they feel the need to protect
these people, supposedly, from this particular disease, you know?
Mothers who we spoke with also thought the mandate was unfair, and many saw a
link between pharmaceutical interests and public health policy:
I think that‘s ridiculous, I think, they‘ll give them a driver‘s license. . .
...
Why not give them a green card, if they are trying to do the right thing? I mean,
again, it‘s their sexual preference. It‘s what they‘re, they‘re choosing to do. If
they choose to have unprotected sex, it‘s on them, and the person they are having
it with. Yes, you want to stop the epidemic, but at the same time, you don‘t want
to put all of these children at risk. But I think it‘s more – I don‘t even know how
much of an epidemic it was. In my mind, it‘s more on making money for the drug
companies.
The concept of choice came up frequently throughout our conversations. Many
girls understood that women coming to the U.S. were strong and capable of making their
own decisions. ―Well, it‘s wrong, even if they‘re not from here, they still should have
their own choice. They choose to came here. I think they should have their own choosing
on whether they want to get a vaccine or not.‖ It did not seem fair that American citizens
did not have to get the vaccine while some immigrant women and girls did.
The vaccine is most effective if given to women before they are sexually active.
By requiring immigrant women as old as twenty-six to get vaccinated, the policy does
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little actual work to protect these women from HPV or to protect Americans from the
spread of HPV from those who may already be infected. Rather, following Fairchild‘s
argument, the work that the mandate does is psychological and political. It communicates
to immigrant women that they are not capable of making decisions about their own
sexual health, and teaches them that in contradistinction to American citizens, they are
risky subjects in need of state intervention. The HPV vaccine mandate for immigrant
women did more for the construction of proper Americanness than it did for actual HPV
prevention.
Merck did not publicly advocate for the immigrant vaccination mandate.
According to members of ACIP, the mandate was an accidental result of their general
population vaccination recommendations, which, consistent with ACIP procedure,
automatically become a rule for immigrants applying for citizenship. Though Merck was
not involved in direct lobbying for this rule, their efforts to define HPV as an exigent
public health issue more generally, and framing adolescent girls as always already at risk,
likely influenced ACIP‘s recommendation process. When the mandate for immigrant
women was challenged, Merck did not push to keep the rule in place. In fact, even
representatives from ACIP acknowledged that they had not understood that the process
would result in this type of mandate and called for its reversal.66 Public resistance from a
small but well organized contingent of reproductive justice and immigrants right
advocates combined with political confusion about the purpose of the law resulted in the
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removal of the mandate for immigrant girls and women from the books in December
2009.67
Unlike the relatively ignored mandate for HPV vaccination of some immigrant
women and girls, mandates for HPV vaccination at the state level caused quite a
controversy across the country, Once the CDC and Advisory Committee for
Immunization Practices (ACIP) recommended HPV vaccination in 2006, twenty-seven
states, including New Mexico, and Washington D.C. began to consider mandates of HPV
vaccination for school entry. Only Virginia and D.C. successfully implemented them.68
While many public health advocates stressed the benefits of the vaccine in terms of
eventual cervical cancer prevention, suspicion and resistance to required HPV
vaccination came from multiple perspectives. Where only a small group of immigrants‘
rights and reproductive justice activists objected publicly to the immigrant mandate,
resistance to mandates for sixth grade girls came from a broad spectrum of opponents.
Cultural conservatives and abstinence-only education proponents worried that any
vaccine geared towards an STI would lead to more adolescents having sex; consumer
rights activists worried about the safety of the vaccine and were distrustful of Merck after
Vioxx, an arthritis drug that they produced, was blamed for over 28,000 deaths before
being taken off the market in 2004. Anti-vaccine groups were suspicious of the U.S.
government imposing medical decisions on their individual rights; women‘s health
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advocates were concerned with potential side effects and future health problems and
concern existed in the medical community that the infrastructure necessary to ensure
delivery of mandatory adolescent vaccination was not in place.69
While by no means representative of the complex HPV policy processes that took
place in states across the country, New Mexico provides an example of the ways in which
health policy decisions reflect what health means in the current moment and exemplifies
the ways in which notions of risky girlhood and of girls at risk were put to work to justify
public health action. Importantly, at the state level the vaccine was framed in terms of
cervical cancer prevention. It was discussed as a public health strategy to protect
vulnerable, at-risk, young girls from cancer. There was not in-depth, public discussion of
whether or not HPV was truly an epidemic worthy of a public health mandate. There was
also very little discussion of the vaccine as a technology that protected against a sexually
transmitted infection. Rather, the discussion focused simply on the presence of a vaccine
that was capable of reducing the risk of cervical cancer in innocent, at-risk populations.
During the regular 2007 legislative session in New Mexico, Republican Senator,
and MD, Steve Komadina sponsored Senate Bill 1174: HPV Vaccine in School-Based
Clinics.70 The Senate Education Committee passed the bill seven to zero and sent it to the
Senate Public Affairs Committee which amended it (changing the HPV vaccine
distribution in school-based clinics for nine to fourteen year-olds to language requiring
the vaccine ―for school entry‖ for girls ―entering the sixth grade‖), and passed it six to
zero. Komadina presented the bill on the Senate floor along with an additional
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amendment and it passed thirty to three.71 The amended bill then passed the House
Health and Government Affairs Committee five to zero and was approved by the House
at large, forty-nine to sixteen. At this point, the bill was largely supported across party
lines. A spokesman for Governor Richardson was even quoted pledging his support for
the bill in an article about a controversy related to a similar bill in Texas that ran in the
New York Times on March 14, 2007.72 It noted that:
In New Mexico, Gov. Bill Richardson, a Democrat who is running for president,
has also pledged to sign cancer vaccination legislation. That state‘s bill, which
includes a provision similar to those in Texas and Virginia allowing for parents to
opt out of having their daughters vaccinated, has already cleared the Legislature.
It is likely to reach Mr. Richardson by tomorrow. ―Governor Richardson will sign
this bill into law, making New Mexico a leader in protecting girls against cervical
cancer,‖ said Gilbert Gallegos, a spokesman for Mr. Richardson. ―This is an
important public health issue that deserves this type of aggressive action.‖73
Though the bill had not been signed when the regular New Mexico legislative session
closed on March 17, 2007 all signs pointed to an HPV mandate for sixth grade girls in
New Mexico.74
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And yet, by April 3rd something had changed. Richardson issued a press release
announcing that he would veto the bill because of a lack of time for education and
implementation.75 He was optimistic about the vaccine‘s promise to protect girls from
cervical cancer. He supported legislation to mandate insurance coverage for the vaccine
and approved state funds for uninsured women who chose to get vaccinated. But he was
no longer willing to approve a state mandate of HPV vaccination for sixth grade girls.76

75

On April 3, Governor Richardson issued a press release stating his intentions to veto SB 1174
which read:‖‘This vaccine is a promising treatment to prevent certain diseases and cancers,‘ stated
Governor Richardson. ‗I included nearly $1 million in funding to provide the HPV Vaccine for young
women not covered by the federal Vaccines for Children Program and am proud to sign legislation that
mandates insurance coverage for the cost of providing this important vaccine.‘ ‗But, since the end of the
session, I have heard from parents, advocates and physicians from all over the state,‘ stated Governor
Richardson. ‗While everyone recognizes the benefits of this vaccine, there is insufficient time to educate
parents, schools and health care providers.‘ ‗For these reasons—a lack of time for public education and the
concern expressed by parents and physicians, I will veto legislation mandating a vaccine for all 6th grade
girls, even with the ability for parents to opt out. This vaccine will still be available to every young woman
in New Mexico and covered by their health insurance.‘ ‗The Department of Health is developing fact sheets
on the vaccine to provide parents enough information so they can make informed decisions about their
children‘s health care. The Department of Health is already working with schools and school nurses across
the state to make the HPV vaccine available to girls who are entering the fifth grade this fall. And any
future legislation should also contain an opt-out provision for parents.‘‖ (State of New Mexico: Office of
the Governor, 2007).
76

It is difficult to tell what factored into the shift in Richardon‘s perspective on the vaccine. The
legislative record does not reflect much resistance during the period in which constituents could testify
before legislative committees. The Legislative Finance Committee‘s Fiscal Impact Report notes that it
received feedback on the bill from the Department of Health, the Public Education Department and the
Health Policy Commission. Though the report notes some concerns with SB 1174, (mainly that there is no
appropriation in the bill despite significant costs attached to providing the vaccine for uninsured vaccineeligible girls, that future vaccines may provide more protection which girls who are vaccinated now may
miss out on, and that the vaccine has been proven to prevent HPV infection and cervical dysplasia which
are thought to lead to cervical cancer but has not been proven to prevent cervical cancer per se) the report is
largely in support of the school mandate. It highlights how effective the rate of protection was in clinical
trials, notes the importance of vaccinating girls before they are sexually active and refers to the
demonstrated efficacy of school entry requirements for vaccination.
HPC notes that state laws that require immunization as a condition of enrollment in
school increase the use of vaccines, reduce disease, lessen racial disparities in vaccine coverage
and increase available funding. According to a recent New England Journal of Medicine
(December 7, 2006) commentary, "Requiring HPV vaccination by law will almost certainly
achieve more widespread protection against the disease than will policies that rely exclusively on
persuasion and education."
Surveys have generally shown that young women are very interested in getting the HPV
vaccine, that parents are willing to have their children vaccinated, and that clinicians are
inclined to offer the vaccine in their practices. Both the American College of
Obstetricians and Gynecologists and the American Academy of Pediatrics endorse the
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There may well have been other players behind the scenes that influenced Richardson‘s
change of heart, or perhaps the backlash from the conservative right against a mandate
ordered by Republican Governor Rick Perry in Texas made him rethink his decision.
Maybe the increasing scrutiny of Merck‘s intensive lobbying and the exposure of
Merck‘s financial backing of ―Women in Government,‖ a group of women legislators
who introduced HPV vaccine mandate bills across the country, made Richardson
uncomfortable. Or maybe Richardson‘s role in the upcoming presidential debates, and the
potential vulnerability that support for mandating a vaccine which prevented the spread
of a sexually transmitted infection could open him up to had something to do with it.
Regardless, Richardson did not feel like he had the public support necessary to pass an
HPV vaccination mandate.
The issues of sex and women‘s control over their own bodies predominated in the
discussions I had in focus groups about the possibility of a state mandate. Though these
issues seemed to be written out of the legislative discussion completely, they are at the
core of the issue of HPV prevention. While some participants supported mandates that
would, in their minds, provide more equitable access to a vaccine capable of saving
women‘s lives, others felt like requiring all girls to get vaccinated years before they may
even become sexually active was a violation of their individual rights. The absence of
sexuality from the discussion of the mandate was a problem for the majority of those
women and girls who spoke. Their comments reflect what Jessica L. Gregg identifies as
an understanding of women‘s bodies as risky, further justifying notions of the need for
control of women‘s bodies and female sexuality. She argues that the link between female
use of the vaccine by their members.
Despite this relatively strong endorsement of the mandate, Governor Richardson chose to reverse his initial
support and veto the bill.
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sexuality and disease reinforces the notion of dangerous female sexuality–of sexuality as
risk–that limits effective disease prevention work. In the United States, with abstinence
education ruling the land during the last decade, and with politicians scared to broach the
topic of teen sexuality, Gregg‘s assertion that women‘s health is reliant on how a woman
thinks about and uses her body sexually is especially prescient. When adolescents do not
get comprehensive sexual education, or when a vaccine designed to prevent a sexually
transmitted infection is couched in terms of cancer prevention rather than STI prevention,
young women are deprived of the ability to make informed decisions about their own
sexual health.77
Many girls I spoke with were supportive of the mandate, understanding the
intentions of state actors as in the best interest of girls and women. Many of them knew
girls who were sexually active in middle school and so they thought that vaccinating sixth
grade girls made sense. Still, they expressed discomfort with the idea of laws mandating
decisions about their bodies and sexual health. For some participants there were clear
parallels with abortion. ―I think that‘s something that is a woman‘s decision and not the
mayor‘s decision; ‗Oh, you can‘t do it.‘ It‘s like, ‗Cause I don‘t want you to.‘ It‘s like
‗well, it‘s not your decision, it‘s not your body, it‘s not your life.‘‖ Even when they
agreed with the sentiment of the mandate, some girls took issue with the lack of choice
for young women when it came to vaccination. ―I think that it‘s in a way, forcing
somebody to get the vaccine is taking away their rights to their bodies, but at the same
time, I understand that if the state does pass the law, it‘s to ensure a woman‘s safety and
health.‖
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Many girls took issue with the ways in which a mandate precluded their own
ability to educate themselves about the vaccine and choose whether it made sense for
them.
I think [the mandate is] a great thing to do, but it‘s a little – it‘s a bit of a
violation for human rights.
So overall, you think it‘s a good thing but it does kind of violate you?
Yeah . . . but if a doctor explained it to the 11- and 12—year-olds a little better, it
wouldn‘t be as much as taking away their rights.
For many of the focus group participants, a mandate would normalize a vaccine that
targets an STI which might make convincing parents to vaccinate their adolescent
daughters a bit easier.
How do you think your parents would respond [to the mandate]?
Well, if it‘s from, like, the nurse and it says, like – I don‘t think it‘d be that bad,
like – probably the parents, like, would react more different if you told them about
it. You‘re like, ―Yeah. I want to get this.‖ Well, then they‘re going to think
differently. But if it‘s a requirement for school, and your nurse asks them, it‘s
going to be way different than if you ask your parents.
Girls understood that the vaccine‘s relationship to adolescent sexuality would alarm some
constituencies. Some thought that parents would get offended by the implications that
their children were having sex.
And like, wouldn‘t some parents get offended though? Because, you know how
parents overreact over stuff. Like, wouldn‘t they get offended from a nurse?
They‘re like, ―Well what are you trying to say? My kid‘s going to have sex or
something?‖
Yeah. ―No, I was trying to say that 80% to 85% of people get this, and if your
kids have sex, I‘d like them to be protected.‖
One girl who went to a private, Catholic school mentioned that she did not think that
Catholic schools would implement an HPV vaccine mandate. ―They‘re all weird about
having sex and when you should have sex, and they, in my opinion, are the types of
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people who would have the mindset to think if you‘re getting the HPV vaccine, you are
going to have sex.‖
While the mandate was not implemented in New Mexico it came very close to
becoming law. The strategy of framing young women as perpetually at-risk of developing
cervical cancer reflects larger trends in public health and medicine.78 Its failure illustrates
the ways in which neoliberalism has challenged the acceptance of traditional populationbased public health measures. When health is understood in neoliberal terms of personal
responsibility, public health issues become individualized. What becomes important is
individual risk and individual survival rather than a concern with populations. The
population approach of the mandate was its downfall. The issue for most opponents was
not whether the vaccine was necessary to protect public health but simply that a mandate
impinged on their rights to make autonomous decisions. However, this obsession with
anti-state, neoliberal understandings of rights and autonomy is not what motivated the
women and girls that I spoke with in their opposition to the mandate. The idea of state
efforts to protect their health seemed plausible. What they took issue with was the ways
in which young women were framed simply as at-risk and in need of state protection
rather than as sexual beings with the ability to understand what an HPV vaccine would
actually mean for them. This discomfort with the state dictating what young women
should do with their bodies is an important counter to the projected notions of
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empowerment and choice that Gardasil’s advertising campaign takes up. The girls and
women who shared their thoughts in the focus groups demonstrate the failure of
neoliberal and contagion discourses to adequately address the concerns of actual girls and
women in the U.S. when it comes to their sexual health.
Theories of medicalization and biomedicalization offer an important lens to
understand the ways in which individualized medicine is propped up in neoliberal
practice, and government-based public health measures have been weakened in the
United States. (The failed vaccination mandates attest to this reality.) They also help to
explain how Gardasil, a vaccine for a health ―problem‖ that was little known until a
pharmaceutical fix was discovered for it, has become an accepted, even encouraged,
technoscientific health solution. Its vast advertising campaigns to consumers rely on a
populace invested in biomedicalization, who seek out health information and choose their
own biomedical technological solutions in the name of consumer autonomy and health.
The reality of biomedicalization requires that patients take on the responsibility of
being informed health consumers and the process itself relies on players beyond doctor
and patient (where the medicalization process largely takes place). The role of the
pharmaceutical industry cannot be overstated. Biomedicalization is seen in the growing
biopolitical economy of medicine and health which privilege purchasing power and
consumer choice in health decision-making. The obsession with obtaining ever better
health (rather than avoiding illness) relies on an acceptance of individuals and
populations as always at risk and is buffered by the never ending supply of medical
technologies that can optimize and enhance bodies. Another key characteristic of
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biomedicalization is the production of group technoscientific identities created around the
shared risk and experience with medical technologies.79
With increasing access to health information via the internet and other
technologies, and in following the neoliberal push to deal with health in terms of personal
responsibility and consumerism, patients demand outcomes from their doctors in
unprecedented ways. The editor of the American Medical Association‘s Journal of Ethics
special issue on Paternalism and Medicine in 2004 notes that much has changed since the
early, paternalistic days of ―doctor as God.‖ ―Patients have taken the reins of health care
with both hands. They come to doctor's offices armed with reams of printouts from health
Web sites. They specifically request medicines or treatments advertised in popular
magazines, on television, and on the Internet. In response to this type of informed
(though sometimes misinformed) patient, many physicians have come to grant a greater
level of autonomy or shared decision-making to all the patients in their practices.‖80 This
―democratization of expertise,‖ core to biomedicalization, creates empowered patients
and challenges the paternalistic nature of medical expertise. However, the challenges of
knowing what information to trust, the potential for misinformation and the avoidance or
dismissal of health information coming from a health professional can have severe
results. ―[W]hile knowledge sources proliferate and access is streamlined in ways
purportedly in the interests of democratizing knowledge, the interests of corporate
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biomedicine predominate.‖81 Mistaking marketing for education has potentially deceptive
results. Direct-to-consumer advertising is a case in point.
For decades, the pharmaceutical industry focused its marketing efforts on medical
professionals, capitalizing on the paternalistic provider-patient dynamic wherein the
recommendation of a medical professional was often all it took to insure use of a specific
drug. In 1997, after years of lobbying by the major television networks, advertising
agencies and pharmaceutical companies, the FDA lightened the restrictions placed on
advertising for prescription drugs, allowing for direct-to-consumer (DTC) advertising.
Whereas previous guidelines required pharmaceutical companies to include most of the
information from consumer warning labels in any advertisements that named both the
product and condition being treated, the new guidelines allowed for drug manufacturers
to provide less information about side effects and safety information associated with their
products. They now had to list only those risks determined to be ―major,‖ and provide
referrals for more information about those risks.82
All at once, the target of pharmaceutical advertisements shifted from health care
professionals to the average consumer.83 Print advertisements previously confined to
medical journals began appearing in gossip and news magazines. This
pharmaceuticalization process brought the larger public into the medicalization process
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through an understanding of all the pharmaceutical opportunities available to them.
Pharmaceutical advertising dollars increased by 145 percent in the next four years–for a
total of $2.7 billion in DTC advertising on television and in popular magazines in 2001
alone.84 By 2005, this spending rose to $4.2 billion.85 Rather than relying solely on the
medical community to promote pharmaceutical technologies, the pharmaceutical industry
could now circumnavigate the middleman and reach consumers directly.
Though drug companies hailed DTC advertising as a democratization of health
information–providing the education that consumers need to make informed health
decisions–the basic motivation for advertising pharmaceuticals is profit. Clearly, drug
manufacturers have a vested interest in shaping perceptions of their products and in
sharing how ―beneficial‖ their drugs are with the public. Clarke notes that the prevalence
of images of ―things medical‖ has increased continuously since the late 1800s. ―In turn,
such images and objects themselves have become constitutive of medical knowledge and
practices.‖86 DTC advertising is extremely effective in shaping and defining health for
the public.
As the marketplace became saturated with advertising offering Americans
happier, healthier lives post-1997, the practice of selling health and the neoliberal
processes of medicalization, biomedicalization and pharmaceuticalization were
increasingly normalized. Consumers learned to recognize ―problems‖ that they had not
84
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previously understood as problems (depression, erectile dysfunction etc.). They learned
about new ―solutions‖ to these problems. And they were taught to ask for those
pharmaceutical solutions by name when they went to see their doctors.87
In his work on how diseases are marketed, Moynihan states that ―[t]he first step in
promoting a blockbuster drug is to build the market by raising public awareness about the
condition the drug is designed to target.‖88 Beginning in September 2005, while the FDA
was still reviewing Gardasil prior to approving its use, Merck was busy promoting HPV
awareness campaigns online and on television (called ―Make the Connection‖ and ―Tell
Someone,‖ respectively) focused on educating the public about the risks of HPV with no
mention of the Gardasil vaccine. Advertisements did not mention that the cervical cancer
death rate in the United States dropped by seventy-four percent between 1955 and 1992
and has continued to decline.89 The drug company was effectively building their market–
planting a seed of paranoia, concern and fear of HPV–under the banner of promoting
women‘s health. Once FDA approval was secured, in June 2006, and Merck could legally
promote Gardasil by name, they would alleviate the fears of the American public with
the new vaccine in their ―One Less‖ and ―I Chose‖ campaigns.90
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The resulting direct-to-consumer advertising campaign created a brand that sold a
feeling as much as a product. Viewers were induced to feel like they were a part of
something important, of making the world a better place for women and girls by
preventing cervical cancer. Merck representatives articulated their motivations behind the
campaign as a way to focus ―on a strong and positive message that is designed to
empower [women and girls] to want to become (or help their daughters want to become)
‗one less‘ person who will battle cervical cancer.‖91 Merck effectively framed the vaccine
as the fulfillment of a pressing need–a need that Merck itself shaped–to end the scourge
of cervical cancer. In educating the public about HPV and its relationship to cervical
cancer, Merck was in many ways providing a useful public service. On the other hand, in
framing their advertising campaign as a ―cause‖–to protect women from preventable
cervical cancer–the company‘s hyperbole was misleading. The goal of their ―education
campaign‖ was not simply to end cervical cancer but to make money. While the threat of
cervical cancer was not completely fabricated and the discovery of the HPV virus was an
important scientific finding with major health implications, Merck could just have easily
focused efforts on increasing awareness about the importance of screening and Pap
smears. Also, the vaccine is offered (at least by implication) as a long-term, even a lifetime vaccine, but–though unacknowledged in the marketing–the duration of protection is
not known past five years. The company was clearly motivated by more than a
commitment to women‘s health.
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When Pharmaceutical Executive magazine chose Gardasil as its 2006 Brand of
the Year, it explained the award by pointing to Merck‘s ability to ―embod[y] the kind of
links between science, commercialization, and humanity that typify great pharmaceutical
breakthroughs. It turned a medical success story into a campaign of empowerment for a
generation of girls and young women. Merck's researchers used visionary science to
produce a vaccine with the potential to eradicate the third-most-common cause of cancer
worldwide, while marketers taught girls and young women how to talk about sensitive
issues in a forthright, unapologetic way.‖92 In their praise, the writers at Pharmaceutical
Executive acknowledged the difficulty that the makers of Gardasil faced–that the market
was relatively ignorant about HPV and therefore didn‘t realize how much they ―needed‖
the vaccine. ―[O]nly 60 percent of women had heard of HPV. And even if they knew
what it was, only 52 percent knew that it could cause cervical cancer or genital warts.‖93
The other obstacle was the difficult terrain of teen sex in marketing a vaccine that
prevented a sexually transmitted infection. The solution that the marketing team working
with Merck came to was to avoid the topic of sexual activity and transmission as much as
possible and to focus on empowerment, choice and healthy mother-daughter
relationships. In this way Merck chose to co-opt a rhetoric of reproductive justice-albeit
one that largely wrote out the issue of sexuality–to neoliberal ends in the marketing of
Gardasil. In so doing, they also utilized neoliberal discourse that relied on the notion that
individuals are responsible for their own health, and persuaded individual health
consumers to search out health solutions via the marketplace.
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Merck very strategically created their audience. Ads did not rely on common
medical advertising strategies like images of an ―expert‖ doctor in a lab coat, or scientific
charts that would lend authority to the claims being made. Rather they relied on images
of female solidarity–a superficial feminism that trumped expertise, and that felt good.
Though it could be argued that sexuality is implicit in the Gardasil advertising, and that a
strong mother-daughter relationship and confident young women are key to good sexual
health, writing sexuality out of the discussion limits true health education and
empowerment by suppressing the actual context for disease risk.
In effect, the DTC advertisements teach that Gardasil is a way for mothers to
protect their daughters and to feel empowered and proactive in the face of the threat of
cervical cancer.94 In many ways they exemplify what Robert Goldman terms ―commodity
feminism‖ where advertisements sell the idea of feminism by connecting the concept of
feminism to material objects.95 Executives at Merck stated that they ―‗learned early on
that moms really wanted to protect their daughters–that protective insight is important.
For young women, they want to empower themselves to take control of their own
destiny.‘‖96 The series of advertisements in the ―I Chose‖ campaign do just that. Mothers
look directly at the viewer and announce ―I chose to get my daughter vaccinated because
I want her to be one less woman affected by cervical cancer.‖ Daughters claim ―I chose
to get vaccinated after my doctor told me Gardasil does more than help prevent cervical
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cancer.‖ Gardasil capitalizes on what Inderpal Grewal identifies as the centrality of the
concept of ―choice‖ for both feminist and neoliberal movements.97
Focus group participants were critical of all the advertisements that we showed
them. One mother‘s cynicism about Gardasil captured the altered landscape resulting
from the normalization of pharmaceuticalization and the onslaught of DTC advertising:
―It‘s just like any other pharmaceutical garbage they‘re selling on TV. You know, 20
years ago you never saw them trying to sell a pill for this and a pill for that, now . . .
[there‘s always a] commercial selling you a pill for something.‖
Most of the mothers and teens that we spoke with were aware of the HPV vaccine
and were familiar with Gardasil advertisements. Those who were not familiar with it by
name recognized the ―One Less‖ tag line. In many cases, participants were critical of the
advertisements. Girls felt like the attempts to capture normal girlhood were false and hard
to relate to:
Like the reason they do the whole stomping the yard and sewing sweaters is, like,
to depict an American teenager and, like, so you can relate to them and be like,
―Oh, I‘m totally them, so I should get [the vaccine] too.‖ But, like, things like
stomping the yard and sewing sweaters aren‘t really on the agenda for most
teenage girls unless you‘re like home-schooled, or Amish.
They noticed that the ads avoided the issue of HPV‘s sexual transmission: ―I was kind of
confused by it. I didn‘t know it was like an STD. I just thought it was cancer.‖
Each focus group was presented with examples of Gardasil’s advertising to
enable more in-depth analysis of the advertising strategies and effectiveness (see
Appendix A & Appendix B). Both examples were print advertisements for Gardasil
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originally published as full page ads in popular magazines. The top half of the first ad
(see Appendix A) consists of text designed to look like a handwritten note, surrounded by
drawings of a two-story house flanked by clouds (some filled with hearts), stick figures
riding bicycles and playing frisbee, and a dog following a cat up a tree (also blooming
with hearts). A smiling sun watches down on the scene. The bottom left portion of the
page is taken up by fine print explaining briefly what Gardasil is, and providing basic
safety information, as well as the vaccine‘s logo, website and hotline number. A woman
and a teenage girl stand in the bottom right hand corner of the page. The girl stands with
her right hand resting on the woman‘s shoulder while she smiles directly into the camera.
Though she looks straight forward, she leans slightly into the older woman. The older
woman stands with both of her hands in her pockets, looking down at the girl with a
smile. Her body faces the camera straight on while her face is directed away from the
viewer, towards the focal point of the image: the happy, healthy, young woman. Both
figures have long, dark, wavy hair that they wear down, both are wearing jeans and both
have jewelry on their left wrists. They are linked both through their physicality and their
styling.
The image and the text combine to teach the viewer that whatever product is
being sold here is both innocent and protective. The ―thoughts‖ scrawled on the top half
of the page are written in a mother‘s voice, but in childlike handwriting, and explain the
motivation to use Gardasil to protect the daughter assumedly depicted below. The
woman‘s smiling, protective gaze leads the viewer‘s eye down to the smiling face of the
younger woman.
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While maternal choice is foregrounded in this advertisement, adolescent sexuality
is completely suppressed. The daughter‘s role in her own health decision making is also
glossed over. The text, surrounded by childlike doodles, declares ―I chose to get my
daughter vaccinated because no matter how old she gets she‘ll always be my little girl.
I‘ll do everything I can to help protect her. Hey, I‘m her mother, that‘s my job. So when
her doctor told me Gardasil helps protect her from cervical cancer and other HPV
diseases I thought this is the protection she deserves.‖ The Gardasil advertisement uses
imagery to construct a viewer who is eager to do something for women, to choose
Gardasil as part of a larger mainstream feminist project of empowerment and health but
who is content to ignore adolescent sexuality and autonomy.
Mothers and teens in all three focus group sites were critical of the strategies
employed in this particular advertisement. Girls were especially attuned to the
representations of the mother-daughter relationship, calling it ―too close,‖ and ―wack.‖
The exclusion of the sexual transmission of HPV was a continued point of frustration for
focus group participants. Girls noted that the portrayal of a close, happy mother-daughter
relationship didn‘t feel realistic in relationship to the sexual activity that the risk of HPV
infection, and cervical cancer, implied. The breezy feel of the ad didn‘t ring true. It was
generally agreed upon that the choice not to overtly address sex in the ads was a strategic
move to make mothers, the clear target of the advertisement, feel comfortable with the
vaccine. As one girl explained: ―sex is offensive to older people . . . so maybe this is
more comforting towards a parent . . . instead of saying ‗sex‘ they‘re using like ‗little
girl‘ and you know, ‗mother‘‖ Caregivers who participated in the focus groups had very
similar critiques. Mothers quickly recognized the omission of sex: ―I think these are kind
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of misleading because if you look at it, it doesn‘t say anywhere, like ‗sexually
transmitted‘.‖
In commissioning this advertisement, Merck was working to visually tie the
Gardasil brand to positive, intimate, mother-daughter relationships and to convince
mothers that choosing the vaccine for their daughters was the responsible, even
empowering, thing to do. Additionally, the all-smiles, easy feel of the image contributes
to a sense that the vaccine is no big deal. Though the campaign was clouded in
controversy–with angry parents up in arms that providing a vaccine protecting young
girls from an STI would promote early sexual activity–this image attempts to redirect the
conversation and focus on maternal choice and empowerment, responsibility and
protection. It provides a way for mothers to prove their good parenting and taps in to a
desire for a closer relationship with their adolescent daughters. Importantly, it lets
mothers overlook the uncomfortable topic of their young daughters as sexual beings.
In addition to the omission of sexual transmission, many of the girls were
bothered by the lack of seriousness that they saw in the ad: ―My mom had cervical
cancer, but um, it‘s a serious thing so I don‘t know why they‘re being . . . nonchalant
about it. Like it should be something more dramatic . . . That upsets me because I feel
like they‘re not taking it serious. So then why should we in turn take it serious? Then you
wonder why girls get [HPV] in the first place.‖
Girls felt like the ads were working to manipulate mothers into vaccinating
daughters through framing vaccination as the responsible choice. Mothers had similar
reactions: ―It makes me feel that if I don‘t do it, I‘m a bad mother. That‘s what it‘s telling

54

you. I mean if you‘re the good mom you‘re gonna go get the shot, that‘s what it‘s telling
you on top.‖
Participants were also shown an advertisement geared towards a different
demographic (see Appendix B). This advertisement appears to be a page in a teenager‘s
notebook. The top half has handwritten notes in dark blue ink. The text is surrounded by
bright pink drawings of high heels, high top sneakers, flowers, clothing, women‘s heads
with different hairstyles, and one sketch of a woman featured in full carrying a purse. The
bottom left hand portion of the page mirrors the fine print in the previous ad. A young
woman, in her late teens or early twenties, takes up the bottom right hand corner of the
page. She wears a short sleeved t-shirt underneath a black vest with white polka dots. Her
hands are casually clasped resting on top of her head. She‘s relaxed, smiling lightly at the
camera. Her hair is up. Her right wrist is encircled by a few bracelets and a necklace
hangs over her shirt. A hand-drawn flower blooms in the corner in front of her left hip
situating her simultaneously in front of and within the page of the notebook. She is
confident, independent, her own woman.
The text, assumedly written in her own hand states: ―I chose to get vaccinated
after my doctor told me the facts. I mean, FACTS are FACTS, and when it comes to my
body and how I can help protect it, I‘m all ears. So when I found out that GARDASIL
helps protect me from cervical cancer and other HPV diseases. I decided to get
vaccinated.‖ The text mirrors her posture: clear, confident, declarative. Like the ad geared
towards mothers, sex is not explicitly invoked as an issue related to the transmission of
HPV or to the HPV vaccine. A difference lies in the depiction here of a young woman in
charge of her own health decision-making. There is no mention of discussing the vaccine
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with a parent. No reference to the woman depicted as anyone‘s ―little girl.‖ Instead, the
text refers to an interaction with a doctor. The young woman makes her own decisions
about her body and her sexual health. She chose to protect herself as an autonomous and
responsible woman.
Mothers and girls responded strongly to the colors and sketches in this
advertisement. One girl commented: ―If I‘d know any better I would have said that this
was perfume or something, maybe deodorant or something like that. This does not [say]
vaccine.‖ Many participants interpreted the drawings as an attempt to draw attention
away from the vaccine.
In viewing this ad, mothers noted that the young woman portrayed seemed
empowered and in control. The girls agreed: ―She looks independent, like she wants to
show like, ‗I‘m independent. I get to do whatever I want.‘‖ Yet many of the girls were
confused about whether the woman depicted was supposed to be representative of them
as twelve to eighteen year-old girls. They commented that she looked at least twenty in
which case the message of the ad was confusing.
I guarantee this woman‘s had sex before. So . . . even if you have had sex before it
could be a possibility that you‘ve already had . . . HPV and if you have, [the
vaccine is] probably not going to protect you. Well, for a twenty year old who
hasn‘t had the shot, [and] has been sexually active . . . then does it really make
sense for her to be talking to other people about getting the shot and being safe
because she still doesn‘t know if she‘s protected against HPV if she‘s already had
it?
Some girls thought that having an older girl in the advertisement helped to avoid the
discomfort around issues of young girl‘s sexuality.
Despite the depiction of an older girl, however, the omission of sex was glaring
here as well. One girl demanded: ―I do not see sex anywhere. I don‘t see sex in these
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drawings. I do not see sex. I see ‗facts, facts,‘ but I do not see sex anywhere. I‘m just
saying. Because this is like sexual stuff. Like, this is a sexually transmitted disease,
obviously, so why isn‘t there sex being presented?‖ A mother noted: ―My first impression
is it doesn‘t say anything–you know; is a young girl going to read this and say, ‗Oh, well,
it‘ll protect me. It‘ll protect me from getting cancer, so I‘m going to do it.‘ Well, it
doesn‘t say anything about sexually transmitted . . . you have sex, you get this. It just
right away reads, to me, ‗Oh, I‘ll get this [vaccine] and not get cancer.‘‖
In some cases, girls who felt like HPV vaccination was an important public health
practice thought that the focus on cancer took away from the urgency necessary to
effectively convince their peers to get vaccinated.
Maybe we should make ads that are more like, uh, attention-grabbing. . . I know
I‘ve seen an ad before, but the reason that it didn‘t stick in my head was one,
because I was not educated. I was just like, ―Oh it‘s a vaccine for cancer. I don‘t
have cancer so I don‘t need it.‖ Then also because it‘s just like, not that appealing
I guess. Like it doesn‘t grab your attention. Like maybe they should put some cold
hard statistics on it.
Others had a critique of the fear tactics that they already saw employed in Gardasil
campaigns, leading viewers to believe that vaccination was the only way to protect
against cervical cancer.
Another theme in the focus groups was an understanding of the ways in which
Merck was working to reach multiple targets with its advertising. In so doing they were
sending mixed messages about just who is empowered to ―choose‖ Gardasil. One girl
noted, ―Well, on this side they‘re saying that the girl should choose and on this side
they‘re saying mothers force your daughters to do it. So it‘s like . . . who do you want to
choose to do it?‖
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Through direct-to-consumer print advertisements like these, the makers of
Gardasil construct a sense that they are committed to, and understand, the needs of real
girls and women. They use imagery of mothers and daughters that connote love and
protection, and child-like drawings that invoke notions of innocence to show a concern
for young women and the need to protect them. Simultaneously, the Gardasil vaccine is
framed as a choice for young women to make on their own. The implication of this is that
women and girls feel as though they are making a free, intelligent choice as a woman
rather than a materialist consumer (though the act of choosing vaccination is carried out
through health consumerism). This allows Merck to tap into feminist discourses of
female solidarity, choice and empowerment. What is disturbing here, beyond the
condescension and blatant marketing strategy, is the way in which Merck‘s efforts to pass
vaccination mandates completely undercut all that they work to appeal to in the vaccine
advertising. Merck takes up the rhetoric of reproductive justice but abstracts it from the
context of larger structural inequity and from sexuality. The pharmaceutical giant
attempts to link consumer choice to a rhetoric of self-determination and autonomy,
melding neoliberal consumerism with a faux feminism, in order to sell more Gardasil.
The focus groups offer a more complex picture. Participants complicate Merck‘s strategy
and incorrect assumptions about the (in)appropriateness of addressing teenage sexuality
in Gardasil advertsing. They recognize the hypocrisy of the ads placed in
contradistinction to the proposed mandates. The manufacturers of Gardasil, while
appealing to the autonomy of women and girls in their advertising campaigns,
simultaneously utilize contamination discourse masked as public health rhetoric to
disallow for individual choice related to the vaccine in state and federal mandates.
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Conclusion
The story of public health in the United States, as recounted in traditional
historical narratives, is one of progress and uplift: the development of an American public
health infrastructure saved the health of the nation. Though important to acknowledge
public health‘s tremendous impact on real people‘s lives in this country, the history of
public health encompasses more than simply the eradication of disease and the extension
of life expectancy. The exposure of state interests distinct from a concern for the health of
its populace, and often working in tandem with the needs of big business and/or invested
in maintenance of racial, economic and gendered hierarchies, allows for an alternative
understanding. The contemporary moment in public health is characterized by neoliberal
policies that have weakened the institution and redirected the focus to individual health
and market solutions.
The example of Gardasil captures the normalization of individual medical
solutions for everyday life. The neoliberal turn in public health emphasizes individual
rights and consumerism. This ideological work is strengthened by the process of
biomedicalization which stresses the personal responsibility for health and the morality
implicit in health decision-making. Pharmaceuticalization foregrounds the importance of
the pharmaceutical industry in providing options for health consumers, in strengthening
reliance on pharmaceutical solutions to health issues, and in altering how public health is
understood. Gardasil allows for a deeper understanding of the ways in which neoliberal
and contamination discourses are utilized through all of these processes to justify
particular public health practices.
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The HPV vaccination mandate for immigrants effectively characterized
immigrant women and girls as excludable based on their status as potential sources of
contagion. If they refused to be vaccinated, their chance for national inclusion was
rejected. The policy had little to do with actual HPV infection rates of immigrant women
and offered very little actual protection for the women being vaccinated or the public that
they supposedly threatened with infection. School mandates avoided the issue of
adolescent sexuality and overestimated the general population‘s commitment to
population health. Policies taught immigrant women that they were risky, suspect and at
the whim of the U.S. government when it came to decisions related to sexual health. They
reaffirmed notions of immigrants as unhealthy risks to public health nationally and taught
adolescent girls that they were perpetually at-risk and powerless to protect themselves.
However seemingly incongruent, the same company that pushed for these mandates
strategically worked to ―educate‖ consumers about health issues and pharmaceutical
solutions, and framed health consumers as empowered health decision-makers, ready to
choose the best health solutions for themselves.
It is important to understand the multiple strategies at work in the consumer and
legislative marketing of Gardasil and to view the efforts of a powerful pharmaceutical
industry, however seemingly well-intentioned, with a critical eye. Gardasil provides an
opportunity to better understand how pharmaceutical interests can work to shape
discourses of health via the state, and how, through a strategic targeting of health
consumers (through advertising) and government (through policy), they can contribute to
the neoliberalization of public health that works to sexualize, racialize, and at times
literally exclude those it purports to protect.
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We see, through the use of neoliberal and contamination discourse in the
promotion of Gardasil, that age-old tropes of women as risky subjects and subjects at risk
and of immigrants as sources of contagion are unfortunately alive and well. The danger
illustrated by the case of Gardasil is of a neoliberal public health that focuses on
individual pharmaceutical solutions rather than prevention and health equity. As girls in
the focus groups in New Mexico pointed out, a more rational policy on both the state and
federal fronts may be one focused on screening and education rather than pharmaceutical
technologies.
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APPENDIX B
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